These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 25327796)

  • 41. The expression of activin receptor-like kinase 1 among patients with head and neck cancer.
    Chien CY; Chuang HC; Chen CH; Fang FM; Chen WC; Huang CC; Huang HY
    Otolaryngol Head Neck Surg; 2013 Jun; 148(6):965-73. PubMed ID: 23447486
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transcriptomic analysis reveals key lncRNAs associated with ribosomal biogenesis and epidermis differentiation in head and neck squamous cell carcinoma.
    Guo YZ; Sun HH; Wang XT; Wang MT
    J Zhejiang Univ Sci B; 2018 Sept.; 19(9):674-688. PubMed ID: 30178634
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Squamous cell carcinoma antigen as a prognostic marker and its correlation with clinicopathological features in head and neck squamous cell carcinoma: Systematic review and meta-analysis.
    Travassos DC; Fernandes D; Massucato EMS; Navarro CM; Bufalino A
    J Oral Pathol Med; 2018 Jan; 47(1):3-10. PubMed ID: 28600896
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic role of regenerating gene-I in patients with stage-IV head and neck squamous cell carcinoma.
    Aboshanif M; Kawasaki Y; Omori Y; Suzuki S; Honda K; Motoyama S; Ishikawa K
    Diagn Pathol; 2016 Aug; 11(1):79. PubMed ID: 27539087
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The paracrine effect of cancer-associated fibroblast-induced interleukin-33 regulates the invasiveness of head and neck squamous cell carcinoma.
    Chen SF; Nieh S; Jao SW; Wu MZ; Liu CL; Chang YC; Lin YS
    J Pathol; 2013 Oct; 231(2):180-9. PubMed ID: 23775566
    [TBL] [Abstract][Full Text] [Related]  

  • 46. ERCC1 protein expression is associated with differential survival in oropharyngeal head and neck squamous cell carcinoma.
    Patel MR; Zhao N; Ang MK; Stadler ME; Fritchie K; Weissler MC; Zanation AM; Harris SL; Funkhouser WK; Olshan AF; Shores CG; Hayes DN
    Otolaryngol Head Neck Surg; 2013 Oct; 149(4):587-95. PubMed ID: 23846458
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High-dose or low-dose cisplatin concurrent with radiotherapy in locally advanced head and neck squamous cell cancer.
    Chang CL; Yuan KS; Wu SY
    Head Neck; 2017 Jul; 39(7):1364-1370. PubMed ID: 28370614
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of p16 expression, nodal status, and smoking on oncologic outcomes of patients with head and neck unknown primary squamous cell carcinoma.
    Dixon PR; Au M; Hosni A; Perez-Ordonez B; Weinreb I; Xu W; Song Y; Huang SH; O'Sullivan B; Goldstein DP; de Almeida JR
    Head Neck; 2016 Sep; 38(9):1347-53. PubMed ID: 27002481
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.
    Fakhry C; Westra WH; Li S; Cmelak A; Ridge JA; Pinto H; Forastiere A; Gillison ML
    J Natl Cancer Inst; 2008 Feb; 100(4):261-9. PubMed ID: 18270337
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic markers in metastatic cutaneous squamous cell carcinoma of the head and neck.
    Hirshoren N; Danne J; Dixon BJ; Magarey M; Kleid S; Webb A; Tiong A; Corry J; Gyorki D
    Head Neck; 2017 Apr; 39(4):772-778. PubMed ID: 28199044
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatitis C Virus RNA Transcript Associates with Prognosis in Non-human Papillomavirus Associated Head and Neck Squamous Cell Carcinoma.
    Tang B; Zhu G; Chen C; Zheng S; Pu Y; Xu Y; Huang H; Wang G; Huang D; Liu Y; Zhang X
    Laryngoscope; 2021 Aug; 131(8):1774-1781. PubMed ID: 33592124
    [TBL] [Abstract][Full Text] [Related]  

  • 52. FGFR1 Is a Potential Prognostic Biomarker and Therapeutic Target in Head and Neck Squamous Cell Carcinoma.
    Koole K; Brunen D; van Kempen PM; Noorlag R; de Bree R; Lieftink C; van Es RJ; Bernards R; Willems SM
    Clin Cancer Res; 2016 Aug; 22(15):3884-93. PubMed ID: 26936917
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic value of PET/CT with (18)F-fluoroazomycin arabinoside for patients with head and neck squamous cell carcinomas receiving chemoradiotherapy.
    Saga T; Inubushi M; Koizumi M; Yoshikawa K; Zhang MR; Obata T; Tanimoto K; Harada R; Uno T; Fujibayashi Y
    Ann Nucl Med; 2016 Apr; 30(3):217-24. PubMed ID: 26662072
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PITX2 and PANCR DNA methylation predicts overall survival in patients with head and neck squamous cell carcinoma.
    Sailer V; Holmes EE; Gevensleben H; Goltz D; Dröge F; de Vos L; Franzen A; Schröck F; Bootz F; Kristiansen G; Schröck A; Dietrich D
    Oncotarget; 2016 Nov; 7(46):75827-75838. PubMed ID: 27716615
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lower circulating platelet counts and antiplatelet therapy independently predict better outcomes in patients with head and neck squamous cell carcinoma.
    Rachidi S; Wallace K; Day TA; Alberg AJ; Li Z
    J Hematol Oncol; 2014 Sep; 7():65. PubMed ID: 25260646
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impaired aldehyde dehydrogenase 1 subfamily member 2A-dependent retinoic acid signaling is related with a mesenchymal-like phenotype and an unfavorable prognosis of head and neck squamous cell carcinoma.
    Seidensaal K; Nollert A; Feige AH; Muller M; Fleming T; Gunkel N; Zaoui K; Grabe N; Weichert W; Weber KJ; Plinkert P; Simon C; Hess J
    Mol Cancer; 2015 Dec; 14():204. PubMed ID: 26634247
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Glyoxalase 1 expression is associated with an unfavorable prognosis of oropharyngeal squamous cell carcinoma.
    Kreycy N; Gotzian C; Fleming T; Flechtenmacher C; Grabe N; Plinkert P; Hess J; Zaoui K
    BMC Cancer; 2017 May; 17(1):382. PubMed ID: 28549423
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HLA traits linked to development of head and neck squamous cell carcinoma affect the progression-free survival of patients.
    Wichmann G; Herchenhahn C; Boehm A; Mozet C; Hofer M; Fischer M; Kolb M; Dietz A
    Oral Oncol; 2017 Jun; 69():115-127. PubMed ID: 28559015
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lymph node ratio as a prognostic factor in head and neck cancer patients.
    Chen CC; Lin JC; Chen KW
    Radiat Oncol; 2015 Aug; 10():181. PubMed ID: 26302761
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aspirin use and head and neck cancer survival: an observational study of 11,623 person-years follow-up.
    Kim SA; Roh JL; Kim SB; Choi SH; Nam SY; Kim SY
    Int J Clin Oncol; 2018 Feb; 23(1):52-58. PubMed ID: 28725937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.